• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Meridian Medical Technologies Expands Bridgeton, Missouri, Operations

Meridian Medical Technologies, a Kindeva Drug Delivery Company and leading global contract development and manufacturing organization focused on drug-device combination products, will expand its operations in Bridgeton, Missouri. The more than $100 million project is expected to create 30 jobs.

The investment will include the purchase of a 155,000-square-foot facility that will be converted to support its production of drug-device combination products and increase its sterile fill-finish capabilities. Operations are scheduled to begin in 2024.

“Meridian brings a strong history of specific expertise to support critical manufacturing capabilities for complex products - addressing a manufacturing shortage we have seen increase over the last several years,” said Milton Boyer, Meridian CEO. “Building a broader platform with the latest technologies and equipment available, coupled with enhanced capabilities in the production of pre-filled syringes and cartridges, will enable Meridian to offer a broader array of CDMO services and increased capacity to our customers.”

For this expansion, Meridian will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.

“It’s exciting to see Meridian Medical Technologies create more opportunities for Missourians in St. Louis,” noted Maggie Kost, Acting Director of the Department of Economic Development. “As Meridian expands while developing lifesaving products, we’re grateful to support its growth. This company is another example of a quality local employer making a positive difference for our state and beyond.”

St. Louis, Missouri-based Meridian is a manufacturer of emergency autoinjectors. The company merged with Kindeva Drug Delivery to create a top five drug-device combination product CDMO.

“Meridian’s expansion brings not only new investment and new jobs to the St. Louis metro, but highlights the continued growth of our bioscience and advanced manufacturing sectors,” added Jason Hall, CEO of Greater St. Louis, Inc. “We are excited by Meridian’s expansion and their commitment to St. Louis and appreciate the hard work and collaboration of the economic development partners at the state and regional level who helped make this project happen.”

Exclusive Research